India Life Science Tools Market to Grow with a CAGR of 6.46% through 2030
Government
support & policies is expected to drive the India Life Science Tools Market
growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Life Science Tools Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India Life Science
Tools Market stood at USD 913.72 Million in 2024 and is anticipated to grow
with a CAGR of 6.46% through 2030. The Indian government has implemented
strategic policies and funding initiatives to accelerate the growth of the life
science tools market, fostering innovation, research, and manufacturing
capabilities. Programs like the Biotechnology Industry Research Assistance
Council (BIRAC) and the National Biopharma Mission have significantly boosted
biopharmaceutical R&D, genomic research, and precision medicine.
Initiatives such
as the Production-Linked Incentive scheme for pharmaceuticals and medical
devices have encouraged local manufacturing of high-end analytical and
diagnostic tools, reducing import dependence. The Genome India Project, aimed
at sequencing diverse genetic profiles, has further expanded the adoption of
next-generation sequencing (NGS) and molecular diagnostics in the country. Government
agencies like ICMR, DBT, and CSIR actively fund research in genomics,
proteomics, and drug discovery, promoting the integration of AI, big data
analytics, and automation in life sciences. Policies supporting clinical
trials, biosimilars, and vaccine development have also enhanced India's
position as a global biotechnology hub, driving demand for cutting-edge life
science tools.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "India Life Science Tools Market”
The India Life
Science Tools Market is segmented into technology, product, end use, regional distribution,
and company.
Based
on Technology, Genomics have emerged as the fastest growing segment in the India
Life Science Tools Market in the forecast period. Pharmaceutical and biotechnology
companies are investing heavily in genomics-driven drug discovery and biomarker
research, leading to the widespread use of PCR, microarrays, and sequencing
technologies. The growing adoption of CRISPR gene-editing techniques and
AI-based genomic data analysis has further fueled innovation. Additionally,
increasing collaborations between biotech firms, hospitals, and research
institutions are driving advancements in genomic applications, making it the
fastest-growing segment in the Indian life science tools market.
Based on Region,
South India have emerged as the fastest growing region in the India Life
Science Tools Market in 2024, driven by the presence of leading biotechnology
hubs, top research institutions, and a strong pharmaceutical industry. Cities
like Bengaluru, Hyderabad, and Chennai are home to numerous biotech startups,
contract research organizations (CROs), and pharmaceutical giants, leading to
increased adoption of advanced life science tools. The region's
robust ecosystem for biopharmaceutical R&D, genetic research, and clinical
trials is fueling demand for genomic, proteomic, and cell biology technologies.
Additionally, collaborations between academic institutions and private sector
players are accelerating innovation in precision medicine, diagnostics, and
drug discovery, making South India the fastest-growing region in the Indian
life science tools market.
Major companies
operating in India Life Science Tools Market are:
- Becton
Dickinson India Private Limited
- Agilent
Technologies India Private Limited
- Illumina
Inc.
- Thermo
Fisher Scientific Inc
- Roche
Products India Private Limited
- Bio-Rad
Laboratories India Private Limited
- Merck
Life Science Private Limited
- Wipro
GE Healthcare Private Limited
- Bruker
India Scientific Pvt Ltd
- Qiagen
India Private Limited
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“India’s life sciences sector is
witnessing a surge in partnerships and foreign investments, driving
advancements in biopharmaceuticals, diagnostics, and research technologies.
Global pharmaceutical and biotech companies are increasingly collaborating with
Indian firms, research institutions, and contract research organizations (CROs)
to enhance drug discovery, clinical trials, and manufacturing capabilities.
These partnerships have accelerated the adoption of cutting-edge life science
tools, facilitating innovation and market expansion”, said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“India Life Science Tools
Market By Technology (Genomic, Proteomics, Cell Biology, Others), By Product
(Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass
Spectrometry, Flow Cytometry, Cloning & Genomic Engineering, NGS,
Microscopy, PCR, Others), By End Use (Government, Pharmaceutical &
Biotechnology Companies, Academic & Research Institutions, Others), By
Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India Life Science Tools Market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Life Science Tools Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com